Jaeb Center for Health Research: Diabetic Retinopathy trials

The registry lists 12 Diabetic Retinopathy studies with Jaeb Center for Health Research as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 2 3Phase 3 9No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• PROMINENT-Eye Ancillary Study (Protocol AD)TerminatedNCT03345901Phase 3Results posted
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDRCompletedNCT02858076Phase 2/3Results posted
• Anti-VEGF Treatment for Prevention of PDR/DMECompletedNCT02634333Phase 3Results posted
• Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic RetinopathyCompletedNCT01489189Phase 3Results posted
• Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N)CompletedNCT00996437Phase 2/3Results posted
• Evaluation of Vitrectomy for Diabetic Macular EdemaCompletedNCT00709319Results posted
• Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic RetinopathyCompletedNCT00445003Phase 3Results posted
• Laser-Ranibizumab-Triamcinolone for Diabetic Macular EdemaCompletedNCT00444600Phase 3Results posted
• A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)CompletedNCT00336323Phase 2Results posted
• Fenofibrate for Prevention of DR WorseningActive, not recruitingNCT04661358Phase 3
• Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes ControlCompletedNCT01323348Phase 3
• The Course of Response to Focal Photocoagulation for DMECompletedNCT00442156